BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30663211)

  • 1. Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome.
    Hirabayashi S; Hasegawa D; Yamamoto K; Nishimura A; Hosoya Y; Shuo T; Kiyokawa N; Miura M; Takahashi N; Manabe A
    Pediatr Blood Cancer; 2019 May; 66(5):e27612. PubMed ID: 30663211
    [No Abstract]   [Full Text] [Related]  

  • 2. Two Elderly Patients with Philadelphia Chromosome Positive Mixed Phenotype Acute Leukemia Who Were Successfully Treated with Dasatinib and Prednisolone.
    Takata H; Ikebe T; Sasaki H; Miyazaki Y; Ohtsuka E; Saburi Y; Ogata M; Shirao K
    Intern Med; 2016; 55(9):1177-81. PubMed ID: 27150875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM
    Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Li XY; Qian JJ; Yang M; Zhang Y; Wang SS; Meng HT; Yu WJ; Tong HY; Ye XJ; Jin J; Zhu HH
    Br J Haematol; 2020 Jun; 189(6):e231-e234. PubMed ID: 32314800
    [No Abstract]   [Full Text] [Related]  

  • 5. Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.
    Slayton WB; Schultz KR; Kairalla JA; Devidas M; Mi X; Pulsipher MA; Chang BH; Mullighan C; Iacobucci I; Silverman LB; Borowitz MJ; Carroll AJ; Heerema NA; Gastier-Foster JM; Wood BL; Mizrahy SL; Merchant T; Brown VI; Sieger L; Siegel MJ; Raetz EA; Winick NJ; Loh ML; Carroll WL; Hunger SP
    J Clin Oncol; 2018 Aug; 36(22):2306-2314. PubMed ID: 29812996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for new thinking: Treatment of relapsed leukemia in children with Down syndrome.
    Rabin K; Izraeli S; Hijiya N; Hitzler J
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27644. PubMed ID: 30724029
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
    Wang J; Shen SH; Hu BF; Wang GL
    Medicine (Baltimore); 2021 Jun; 100(25):e26440. PubMed ID: 34160436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Philadelphia chromosome-positive B-lymphoblastic lymphoma involving the genitourinary system and bone at initial diagnosis and relapse.
    Zheng L; Hu S
    Blood; 2017 Sep; 130(12):1483. PubMed ID: 28935645
    [No Abstract]   [Full Text] [Related]  

  • 9. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
    Short NJ; Kantarjian HM; Sasaki K; Ravandi F; Ko H; Cameron Yin C; Garcia-Manero G; Cortes JE; Garris R; O'Brien SM; Patel K; Khouri M; Thomas D; Jain N; Kadia TM; Daver NG; Benton CB; Issa GC; Konopleva M; Jabbour E
    Am J Hematol; 2017 Mar; 92(3):238-243. PubMed ID: 28006851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab.
    Puzzolo MC; Radice G; Peragine N; de Propris MS; Mariglia P; Vignetti M; Vitale A; Bassan R; Annunziata M; Gaidano G; Rambaldi A; Chiaretti S; Guarini A; FoĆ  R
    Blood; 2021 Dec; 138(22):2290-2293. PubMed ID: 34297829
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Wang T; Cheng C; Peng L; Gao M; Xi M; Rousseaux S; Khochbin S; Wang J; Mi J
    J Cell Mol Med; 2018 Mar; 22(3):1614-1626. PubMed ID: 29266867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: possible use of interferon on the basis of some novel concepts.
    Ohyashiki K; Ohyashiki JH; Toyama K
    Leuk Lymphoma; 1993 Jan; 9(1-2):43-8. PubMed ID: 8477200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting BCR-ABL and JAK2 in Ph+ ALL.
    Hantschel O
    Blood; 2015 Feb; 125(9):1362-3. PubMed ID: 25721043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].
    Hoshino T; Tahara K; Miyawaki K; Hatsumi N; Takada S; Miyawaki S; Sakura T
    Rinsho Ketsueki; 2010 Mar; 51(3):181-8. PubMed ID: 20379112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Leonard JT; Rowley JS; Eide CA; Traer E; Hayes-Lattin B; Loriaux M; Spurgeon SE; Druker BJ; Tyner JW; Chang BH
    Sci Transl Med; 2016 Aug; 8(354):354ra114. PubMed ID: 27582059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A balancing act: Blinatumomab use in a rare occurrence of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in an adolescent patient with Down syndrome.
    Rav ES; Wahba A; Patnaik A; Toruner G; Hittle A; Toepfer L; Roth M; Cuglievan B; Nunez C; McCall D
    Pediatr Blood Cancer; 2023 May; 70(5):e30191. PubMed ID: 36602024
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute lymphoblastic leukemia with Philadelphia chromosome in a 39-year-old woman with Down syndrome presenting as meningitis and fulminant liver failure.
    Hjorth SV; Vainer B; Petersen BL; Larsen FS; Hasle H
    Leuk Res; 2010 Nov; 34(11):e297-9. PubMed ID: 20598743
    [No Abstract]   [Full Text] [Related]  

  • 19. Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
    Ureshino H; Nishioka A; Kojima K; Kizuka H; Sano H; Shindo T; Kubota Y; Ando T; Kimura S
    Intern Med; 2016; 55(18):2703-6. PubMed ID: 27629971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia.
    Thomas D
    Lancet Oncol; 2012 Sep; 13(9):860-2. PubMed ID: 22935232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.